David Noble Email

Data Scientist II . A-Alpha Bio

Current Roles

Employees:
58
Revenue:
$7.3M
About
At A-Alpha Bio, we aim to accelerate target discovery, library screening, and preclinical drug characterization by providing cell-based tools for quantitative and high-throughput measurements of protein interactions. Current approaches for measuring protein interactions are insufficient for many drug development applications due to low accuracy or throughput. We are a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck. AlphaSeq is a revolutionary cell-based platform technology that will fundamentally change the way that protein interactions are measured. We are seeking industry partnerships to evaluate the use of AlphaSeq for a variety of drug development applications. A-Alpha Bio, Inc. was founded in 2017 as a spinout from the University of Washington's Institute for Protein Design and Center for Synthetic Biology.
A-Alpha Bio Address
2101 4th Avenue
Seattle, WA
United States
A-Alpha Bio Email

Past Companies

A-Alpha BioData Scientist II
A-Alpha BioData Scientist
Ingolia Lab - University of California, BerkeleyUndergraduate Researcher - Computational Biology

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.